Seeking Alpha

Shares of BioScrip (BIOS) gain 7% after BB&T initiates with a Buy rating and an elevated...

Shares of BioScrip (BIOS) gain 7% after BB&T initiates with a Buy rating and an elevated price target of $10 - repping 61% upside potential for shares of the pharmacy and home health provider.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs